Rare diseases
Investigational molecules
Locations
Back to Slovakia36 clinical trials in Petrzalka, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
SlovakiaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
SlovakiaWeight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone
SlovakiaBaricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis
SlovakiaA study comparing the effectiveness of vorolanib and aflibercept in patients with diabetic macular edema
SlovakiaA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
SlovakiaComparing weekly insulin icodec and daily insulin glargine with insulin aspart in adults with type 1 diabetes: a 26-week study of blood sugar control
SlovakiaStudy Comparing EYP-1901 and Aflibercept for Patients with Wet Age-Related Macular Degeneration
SlovakiaStudy comparing semaglutide with insulin glargine in overweight adults with type 2 diabetes: effectiveness of combined treatment versus insulin alone
SlovakiaStudy on the Effectiveness and Safety of BAY 3283142 in Reducing Urine Albumin for Patients with Chronic Kidney Disease
SlovakiaStudy on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment
SlovakiaStudy on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on cardiovascular diseases and preventive treatments, including studies on atherosclerosis, myocardial infarction, and stroke prevention.
Novel therapies being evaluated include inclisiran and pelacarsen for reducing cardiovascular events.
Research initiatives targeting metabolic conditions, with particular emphasis on obesity, diabetes, and lipid disorders management.
Studies evaluating new treatments like semaglutide and specialized medications for severe metabolic disorders.
Innovative research into autoimmune disorders, including trials for Sjögren's Syndrome, lupus, and chronic urticaria.
Testing advanced biologics and targeted therapies for autoimmune condition management.
Clinical research focusing on neurological disorders and mental health conditions, including schizophrenia and neurogenic conditions.
Evaluation of new therapeutic approaches for complex neurological disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
